Skip to main content
Caplight Logo









Shiru

Shiru

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.shiru.com/

Last Round

Series B

Nov 12, 2024

Total Funding Raised

$36.52M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Shiru is a biotechnology company that uses artificial intelligence, bioinformatics, and precision biology to discover and develop sustainable, high-performance protein ingredients for the food, personal care, and agriculture industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Application

Keywords

food techalternative proteinplant-based ingredientsai-discovered ingredientsprecision fermentationingredient discoverynovel proteinsplant-based fatsbiotech foodfood formulationsynthetic biologysustainable foodCPG innovationdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shiru Comparables

Compare Shiru with similar companies based on industry and business-model similarity.

Shiru comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuritas
80%
Brightseed
79%
Perfect Day
77%

Shiru Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 12, 2024
Series AOct 27, 2021
GrantApr 30, 2021
SeedOct 24, 2019

Key People

Founding team and executive leadership

Jasmin Hume

Founder And CEO

Founding Team

Duncan Seay

Fractional CFO Strategic Advisor

Executive Team

Shiru Investors

Notable investors and investment history

Shiru investors
InvestorRounds
S.q.pSeries A
Peak State VenturesSeries A, Seed
EmlesSeries A
Twenty Two VenturesSeed
SALTSeries A
CPT CapitalSeries A, Seed, Series B
Emles Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 32% MoM, reaching 4.1K.

  • Apr 6, 2026

    Collaborating to develop a next-generation egg replacement.

Shiru Filings

Explore SEC and related filing metadata, where available.

Shiru filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shiru's valuation, stock price, and market status.

Is Shiru a public or private company?

Shiru is a private company.

What is the current stock price of Shiru?

Shiru is a private company with no public stock price. No recent secondary market data is available.

How much is Shiru worth (valuation)?

Valuation information for Shiru is not publicly available.

Can I buy Shiru stock?

Shiru shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Shiru's last funding round?

Shiru's most recent funding round was Series B on November 12, 2024.

Who are the main investors in Shiru?

Key investors in Shiru include Lux Capital, S2G Investments.

Will Shiru IPO soon?

No public IPO plans have been announced for Shiru.

How can I track Shiru secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shiru's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAlameda, California
Employee Range14
Year Founded2019
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?